Case Report: [225Ac]Ac-PSMA-617 therapy in a patient with metastatic castration-resistant prostate cancer (mCRPC) and intracranial meningioma - Top-Institutions - MDSpire

Case Report: [225Ac]Ac-PSMA-617 therapy in a patient with metastatic castration-resistant prostate cancer (mCRPC) and intracranial meningioma

  • By

  • Iskander Musabaev

  • Sergey Goryaynov

  • Tatiana Yu Kochetova

  • Valerii Krylov

  • Sergey Ivanov

  • May 29, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Oncology

  • #2

    University of California Los Angeles (UCLA) Jonsson Comprehensive Cancer Center
    University of California Los Angeles (UCLA) Jonsson Comprehensive Cancer Center

    Los Angeles, CA

    Key Differentiators

    • Oncology

  • #3

    Peter MacCallum Cancer Centre
    Peter MacCallum Cancer Centre

    Melbourne, VIC

    Key Differentiators

    • Oncology

  • #4

    Medical Radiological Research Center
    Medical Radiological Research Center

    N/A, N/A

    Key Differentiators

    • Radiology

Original Source(s)

Case Report: [225Ac]Ac-PSMA-617 therapy in a patient with metastatic castration-resistant prostate cancer (mCRPC) and intracranial meningioma

  • by Iskander Musabaev, Sergey Goryaynov, Tatiana Yu Kochetova, Valerii Krylov, Sergey Ivanov

  • May 29, 2026

Related Content

Evolution of therapeutic paradigms in Hodgkin lymphoma: from “cure-oriented” to “functional cure”

MRI perfusion in evaluating ovarian masses: diagnostic performance of wash out rate

Artificial intelligence for optimization of immunotherapy: current applications and transformative potential